Market Highlights
Infectious diseases includes diseases like tuberculosis, hepatitis and
many other diseases caused by viruses, fungi or bacteria. Asia Pacific region
has tropical climate and more humidity which is more suitable for the growth of
the different microorganisms which can cause different diseases. Increasing
prevalence of Infectious diseases such as tuberculosis and AIDS in Asia
Pacific region is the major driving factor for the growth of the market.
Increasing burden of different infectious diseases has increase the demand for
the different diagnostic test and treatment for the different infectious
diseases. Infectious
Disease Treatment Market Share in APAC Share is
expected to grow at a CAGR of 2.9% during forecasted period.
Segmentation:
Asia Pacific infectious disease diagnosis & treatment market outlook is segmented
· on the basis of application into AIDS, Tuberculosis (TB), Hepatitis, HPV, and others.
· On the basis treatment it is segmented into Antibiotics, antivirals, antifungals, anti-parasitic, alternative medicine and others.
· On the basis of diagnostic techniques they are immunoassays, PCR, cell cultures and other
· By end user the market is segmented as hospitals, clinics, reference labs and others
Due to increasing prevalence infectious diseases like tuberculosis and AIDS in Asia Pacific region has attracted many companies for the development of the market in Asia Pacific region. Companies are concentrating on the development of new and better diagnostic test and treatment for the different diseases. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.
Key Players:
The major key player for the Asia Pacific infectious
disease diagnosis & treatment market are
·
Abbott Laboratories (US),
·
Becton Dickinson & Co. (US),
·
Alere, Inc. (US),
·
Bio-Rad Laboratories (US),
·
Cipla (India),
·
Danaher Corporation (US),
·
Glaxosmithkline (UK),
·
IPCA Laboratories (India),
·
Pfizer (US),
·
Roche Diagnostics (Switzerland),
·
Johnson And Johnson (US),
·
Novartis International (Switzerland),
·
Siemens Healthcare (Germany),
·
Thermo Fisher Scientific, Inc. (US),
·
Vertex Pharmaceuticals (US) and others
Regional Analysis
On regional basis, China commands the largest market for
Asia Pacific infectious disease diagnosis & treatment market. Presence of
huge population and increasing peoples suffering from TB are the major reason
for the development of this market in China. China contribute 10 % of total TB
population in the world. India has the second largest market for infectious
disease diagnosis & treatment. Presence of highest TB patient in the world
is the major driving factor for the market. Continuous development in the
healthcare sector and increasing healthcare expenditure is also increased the
infectious disease diagnosis & treatment market in India.
Related reports-
Global
DPT vaccine Market Research Report- Forecast To 2030
Medical
Writing Market Research Report - Forecast till 2030
Dental
Consumables Market Research Report- North America Forecast till 2030
About US:
Market Research Future (MRFR) enable customers to unravel
the complexity of various industries through Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed
Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media
Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
